| First Author | Stepanova V | Year | 2008 |
| Journal | Blood | Volume | 112 |
| Issue | 1 | Pages | 100-10 |
| PubMed ID | 18337556 | Mgi Jnum | J:137279 |
| Mgi Id | MGI:3798715 | Doi | 10.1182/blood-2007-07-104455 |
| Citation | Stepanova V, et al. (2008) Nuclear translocation of urokinase-type plasminogen activator. Blood 112(1):100-10 |
| abstractText | Urokinase-type plasminogen activator (uPA) participates in diverse (patho)physiological processes through intracellular signaling events that affect cell adhesion, migration, and proliferation, although the mechanisms by which these occur are only partially understood. Here we report that upon cell binding and internalization, single-chain uPA (scuPA) translocates to the nucleus within minutes. Nuclear translocation does not involve proteolytic activation or degradation of scuPA. Neither the urokinase receptor (uPAR) nor the low-density lipoprotein-related receptor (LRP) is required for nuclear targeting. Rather, translocation involves the binding of scuPA to the nucleocytoplasmic shuttle protein nucleolin through a region containing the kringle domain. RNA interference and mutational analysis demonstrate that nucleolin is required for the nuclear transport of scuPA. Furthermore, nucleolin is required for the induction smooth muscle alpha-actin (alpha-SMA) by scuPA. These data reveal a novel pathway by which uPA is rapidly translocated to the nucleus where it might participate in regulating gene expression. |
